UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

Journal of Clinical Microbiology, 1999-10, Vol.37 (10), p.3223-3228

1999

Volltextzugriff (PDF)

BMI1, The polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma

Genes chromosomes & cancer, 2013-10, Vol.52 (10), p.928-944

2013

Volltextzugriff (PDF)

Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians

Annals of medicine (Helsinki), 2013-09, Vol.45 (5-6), p.413-422

2013

Volltextzugriff (PDF)

Effectiveness and Safety of Ibrutinib in Patients with Mantle Cell Lymphoma (MCL) in Belgian Routine Clinical Practice: 3-Year Follow-up

Blood, 2022-11, Vol.140 (Supplement 1), p.3661-3662

2022

Volltextzugriff (PDF)

P-162: Compass: a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients

Clinical lymphoma, myeloma and leukemia, 2021-10, Vol.21, p.S124-S124

2021

Volltextzugriff (PDF)

The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis

Experimental hematology & oncology, 2015-09, Vol.4 (1), p.26-26, Article 26

2015

Volltextzugriff (PDF)

Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial

BLOOD, 2014-12, Vol.124 (21), p.3458-3458

2014

Volltextzugriff (PDF)

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation : A prospective cohort study of the european group for blood and marrow transplantation

Blood, 1998-11, Vol.92 (10), p.3599-3604

1998

Volltextzugriff (PDF)

Long-term follow-up of the GELA LNH 03-7B study: A prospective phase II study of 150 patients over 80 years with diffuse large B-cell lymphoma (DLBCL) treated with RminiCHOP

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.8536-8536

2013

Volltextzugriff (PDF)

Anemia and the Use of Erythropoietic-Stimulating Agents with Ruxolitinib in the COMFORT-II Study

Blood, 2011-11, Vol.118 (21), p.5147-5147

2011

Volltextzugriff (PDF)

The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF)

Blood, 2012-11, Vol.120 (21), p.2838-2838

2012

Volltextzugriff (PDF)

The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome

British journal of haematology, 2010-06, Vol.149 (6), p.901-904

2010

Volltextzugriff (PDF)

Myelofibrosis patients in Belgium: disease characteristics

Acta clinica belgica (English ed. Online), 2015-04, Vol.70 (2), p.105-111

2015

Volltextzugriff (PDF)

Consensus on the clinical use of myeloid growth factors

Current opinion in hematology, 1996, Vol.3 (3), p.241-246

1996

Volltextzugriff (PDF)

Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes

Leukemia & lymphoma, 2012-12, Vol.53 (12), p.2449-2455

2012

Volltextzugriff (PDF)

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

Blood, 2012-11, Vol.120 (21), p.57-57

2012

Volltextzugriff (PDF)

International Observational Study On Bortezomib (VELCADE) in Relapsed Multiple Myeloma: Preliminary Efficacy and Quality of Life (QoL) Results From the Belgian Population

Blood, 2009-11, Vol.114 (22), p.4523-4523

2009

Volltextzugriff (PDF)

BMI1, the Polycomb-Group Gene, Is Recurrently Targeted by Genomic Rearrangements in Progressive B-Cell Leukemia/Lymphoma

Blood, 2009-11, Vol.114 (22), p.1099-1099

2009

Volltextzugriff (PDF)

The T(14;20)(q32;q12) : A Rare Cytogenetic Change in Multiple Myeloma Associated with Poor Outcome

Blood, 2008-11, Vol.112 (11), p.2718-2718

2008

Volltextzugriff (PDF)

Gain-of-Function WASP Mutations in Pediatric and Adult Patients with Myelodysplasia or AML

Blood, 2006-11, Vol.108 (11), p.4516-4516

2006

Volltextzugriff (PDF)

Life 2.0: A Comprehensive Cross-Sectional Profiling of the ‘New Normal’ in 244 Long-Term Allogeneic Hematopoietic Cell Transplantation Survivors Compared to the General Population

Biology of blood and marrow transplantation, 2020-03, Vol.26 (3), p.S354-S354

2020

Volltextzugriff (PDF)

Urban renaissance: from physical beautification to social empowerment: Lessons from Bruges-Cultural Capital of Europe 2002

City (London, England), 2004-07, Vol.8 (2), p.229-235

2004

Volltextzugriff (PDF)

Lessons from Bruges - cultural capital of Europe 2004

City (London, England), 2004-07, Vol.8 (2), p.229-235

2004

Volltextzugriff (PDF)

Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature

Transplant international, 2002-03, Vol.15 (2-3), p.117-123

2002

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(65)

Sprache

Englisch
(65)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

BMI1, The polycomb-group gene, is recurrently targeted by genomic rearrangements in progressive B-cell leukemia/lymphoma

Diagnosis and follow-up of monoclonal gammopathies of undetermined significance; information for referring physicians

Effectiveness and Safety of Ibrutinib in Patients with Mantle Cell Lymphoma (MCL) in Belgian Routine Clinical Practice: 3-Year Follow-up

P-162: Compass: a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients

The use of erythropoiesis-stimulating agents with ruxolitinib in patients with myelofibrosis in COMFORT-II: an open-label, phase 3 study assessing efficacy and safety of ruxolitinib versus best available therapy in the treatment of myelofibrosis

Impact of Response Quality on Survival Outcomes in Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts): Results from the First Trial

Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation : A prospective cohort study of the european group for blood and marrow transplantation

Long-term follow-up of the GELA LNH 03-7B study: A prospective phase II study of 150 patients over 80 years with diffuse large B-cell lymphoma (DLBCL) treated with RminiCHOP

Anemia and the Use of Erythropoietic-Stimulating Agents with Ruxolitinib in the COMFORT-II Study

The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF)

The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome

Myelofibrosis patients in Belgium: disease characteristics

Consensus on the clinical use of myeloid growth factors

Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

International Observational Study On Bortezomib (VELCADE) in Relapsed Multiple Myeloma: Preliminary Efficacy and Quality of Life (QoL) Results From the Belgian Population

BMI1, the Polycomb-Group Gene, Is Recurrently Targeted by Genomic Rearrangements in Progressive B-Cell Leukemia/Lymphoma

The T(14;20)(q32;q12) : A Rare Cytogenetic Change in Multiple Myeloma Associated with Poor Outcome

Gain-of-Function WASP Mutations in Pediatric and Adult Patients with Myelodysplasia or AML

Treatment of Older Patients, 40 to 70 Years of Age, with Acute Lymphoblastic Leukemia According to a Chemotherapy Regimen That Includes a Novel Pre-Phase for Rapid Tumor Load Reduction. Results of the Dutch-Belgian HOVON-71 Study

Life 2.0: A Comprehensive Cross-Sectional Profiling of the ‘New Normal’ in 244 Long-Term Allogeneic Hematopoietic Cell Transplantation Survivors Compared to the General Population

Urban renaissance: from physical beautification to social empowerment: Lessons from Bruges-Cultural Capital of Europe 2002

Lessons from Bruges - cultural capital of Europe 2004

Aplastic anemia after transplantation for non-A, non-B, non-C fulminant hepatic failure: case report and review of the literature

Suchergebnisse filtern